Penetrating Macrophage-Based Nanoformulation for Periodontitis Treatment

Periodontitis is a chronic inflammatory disease caused by the interaction of oral microorganisms with the host immune response. Porphyromonas gingivalis (P.g.) acts as a key mediator in subverting the homeostasis of the local immune system. On the one hand, P.g. inhibits phagocytosis and the killing...

Full description

Saved in:
Bibliographic Details
Published inACS nano Vol. 16; no. 11; pp. 18253 - 18265
Main Authors Yan, Na, Xu, Junchao, Liu, Guolin, Ma, Chao, Bao, Lin, Cong, Yalin, Wang, Ziyao, Zhao, Yuliang, Xu, Weihua, Chen, Chunying
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 22.11.2022
Subjects
Online AccessGet full text
ISSN1936-0851
1936-086X
1936-086X
DOI10.1021/acsnano.2c05923

Cover

Abstract Periodontitis is a chronic inflammatory disease caused by the interaction of oral microorganisms with the host immune response. Porphyromonas gingivalis (P.g.) acts as a key mediator in subverting the homeostasis of the local immune system. On the one hand, P.g. inhibits phagocytosis and the killing capacity of immune cells. On the other hand, P.g. increases selective cytokine release, which is beneficial to its further proliferation. Here, we prepared a penetrating macrophage-based nanoformulation (MZ@PNM)-encapsulating hydrogel (MZ@PNM@GCP) that responded to the periodontitis microenvironment. MZ@PNM targeted P.g. via the Toll-like receptor complex 2/1 (TLR2/1) on its macrophage-mimicking membrane, then directly killed P.g. through disruption of bacterial structural integrity by the cationic nanoparticles and intracellular release of an antibacterial drug, metronidazole (MZ). Meanwhile, MZ@PNM interrupted the specific binding of P.g. to immune cells and neutralized complement component 5a (C5a), preventing P.g. subversion of periodontal host immune response. Overall, MZ@PNM@GCP showed potent efficacy in periodontitis treatment, restoring local immune function and killing pathogenic bacteria, while exhibiting favorable biocompatibility, all of which have been demonstrated both in vivo and in vitro.
AbstractList Periodontitis is a chronic inflammatory disease caused by the interaction of oral microorganisms with the host immune response. Porphyromonas gingivalis (P.g.) acts as a key mediator in subverting the homeostasis of the local immune system. On the one hand, P.g. inhibits phagocytosis and the killing capacity of immune cells. On the other hand, P.g. increases selective cytokine release, which is beneficial to its further proliferation. Here, we prepared a penetrating macrophage-based nanoformulation (MZ@PNM)-encapsulating hydrogel (MZ@PNM@GCP) that responded to the periodontitis microenvironment. MZ@PNM targeted P.g. via the Toll-like receptor complex 2/1 (TLR2/1) on its macrophage-mimicking membrane, then directly killed P.g. through disruption of bacterial structural integrity by the cationic nanoparticles and intracellular release of an antibacterial drug, metronidazole (MZ). Meanwhile, MZ@PNM interrupted the specific binding of P.g. to immune cells and neutralized complement component 5a (C5a), preventing P.g. subversion of periodontal host immune response. Overall, MZ@PNM@GCP showed potent efficacy in periodontitis treatment, restoring local immune function and killing pathogenic bacteria, while exhibiting favorable biocompatibility, all of which have been demonstrated both in vivo and in vitro.Periodontitis is a chronic inflammatory disease caused by the interaction of oral microorganisms with the host immune response. Porphyromonas gingivalis (P.g.) acts as a key mediator in subverting the homeostasis of the local immune system. On the one hand, P.g. inhibits phagocytosis and the killing capacity of immune cells. On the other hand, P.g. increases selective cytokine release, which is beneficial to its further proliferation. Here, we prepared a penetrating macrophage-based nanoformulation (MZ@PNM)-encapsulating hydrogel (MZ@PNM@GCP) that responded to the periodontitis microenvironment. MZ@PNM targeted P.g. via the Toll-like receptor complex 2/1 (TLR2/1) on its macrophage-mimicking membrane, then directly killed P.g. through disruption of bacterial structural integrity by the cationic nanoparticles and intracellular release of an antibacterial drug, metronidazole (MZ). Meanwhile, MZ@PNM interrupted the specific binding of P.g. to immune cells and neutralized complement component 5a (C5a), preventing P.g. subversion of periodontal host immune response. Overall, MZ@PNM@GCP showed potent efficacy in periodontitis treatment, restoring local immune function and killing pathogenic bacteria, while exhibiting favorable biocompatibility, all of which have been demonstrated both in vivo and in vitro.
Periodontitis is a chronic inflammatory disease caused by the interaction of oral microorganisms with the host immune response. (P.g.) acts as a key mediator in subverting the homeostasis of the local immune system. On the one hand, P.g. inhibits phagocytosis and the killing capacity of immune cells. On the other hand, P.g. increases selective cytokine release, which is beneficial to its further proliferation. Here, we prepared a penetrating macrophage-based nanoformulation (MZ@PNM)-encapsulating hydrogel (MZ@PNM@GCP) that responded to the periodontitis microenvironment. MZ@PNM targeted P.g. via the Toll-like receptor complex 2/1 (TLR2/1) on its macrophage-mimicking membrane, then directly killed P.g. through disruption of bacterial structural integrity by the cationic nanoparticles and intracellular release of an antibacterial drug, metronidazole (MZ). Meanwhile, MZ@PNM interrupted the specific binding of P.g. to immune cells and neutralized complement component 5a (C5a), preventing P.g. subversion of periodontal host immune response. Overall, MZ@PNM@GCP showed potent efficacy in periodontitis treatment, restoring local immune function and killing pathogenic bacteria, while exhibiting favorable biocompatibility, all of which have been demonstrated both and .
Periodontitis is a chronic inflammatory disease caused by the interaction of oral microorganisms with the host immune response. Porphyromonas gingivalis (P.g.) acts as a key mediator in subverting the homeostasis of the local immune system. On the one hand, P.g. inhibits phagocytosis and the killing capacity of immune cells. On the other hand, P.g. increases selective cytokine release, which is beneficial to its further proliferation. Here, we prepared a penetrating macrophage-based nanoformulation (MZ@PNM)-encapsulating hydrogel (MZ@PNM@GCP) that responded to the periodontitis microenvironment. MZ@PNM targeted P.g. via the Toll-like receptor complex 2/1 (TLR2/1) on its macrophage-mimicking membrane, then directly killed P.g. through disruption of bacterial structural integrity by the cationic nanoparticles and intracellular release of an antibacterial drug, metronidazole (MZ). Meanwhile, MZ@PNM interrupted the specific binding of P.g. to immune cells and neutralized complement component 5a (C5a), preventing P.g. subversion of periodontal host immune response. Overall, MZ@PNM@GCP showed potent efficacy in periodontitis treatment, restoring local immune function and killing pathogenic bacteria, while exhibiting favorable biocompatibility, all of which have been demonstrated both in vivo and in vitro.
Author Wang, Ziyao
Xu, Junchao
Bao, Lin
Ma, Chao
Cong, Yalin
Zhao, Yuliang
Chen, Chunying
Xu, Weihua
Yan, Na
Liu, Guolin
AuthorAffiliation CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience
Institute of Genetics and Developmental Biology
Liangxiang Hospital
AuthorAffiliation_xml – name: Institute of Genetics and Developmental Biology
– name: Liangxiang Hospital
– name: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience
Author_xml – sequence: 1
  givenname: Na
  orcidid: 0000-0003-1900-6405
  surname: Yan
  fullname: Yan, Na
  organization: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience
– sequence: 2
  givenname: Junchao
  surname: Xu
  fullname: Xu, Junchao
  organization: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience
– sequence: 3
  givenname: Guolin
  surname: Liu
  fullname: Liu, Guolin
  organization: Liangxiang Hospital
– sequence: 4
  givenname: Chao
  surname: Ma
  fullname: Ma, Chao
– sequence: 5
  givenname: Lin
  surname: Bao
  fullname: Bao, Lin
  organization: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience
– sequence: 6
  givenname: Yalin
  surname: Cong
  fullname: Cong, Yalin
  organization: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience
– sequence: 7
  givenname: Ziyao
  surname: Wang
  fullname: Wang, Ziyao
  organization: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience
– sequence: 8
  givenname: Yuliang
  orcidid: 0000-0002-9586-9360
  surname: Zhao
  fullname: Zhao, Yuliang
  email: zhaoyl@nanoctr.cn
  organization: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience
– sequence: 9
  givenname: Weihua
  surname: Xu
  fullname: Xu, Weihua
  email: whxu@genetics.ac.cn
  organization: Institute of Genetics and Developmental Biology
– sequence: 10
  givenname: Chunying
  orcidid: 0000-0002-6027-0315
  surname: Chen
  fullname: Chen, Chunying
  email: chenchy@nanoctr.cn
  organization: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36288552$$D View this record in MEDLINE/PubMed
BookMark eNp9kD1PwzAQhi1URFtgZkMZkVCoP-LYGaECilQ-BpDYIie5lFSJXWxn4N9jaOiABNOd7p73pHumaKSNBoROCL4gmJKZKp1W2lzQEvOMsj00IRlLYyzT19Gu52SMps6tMeZCivQAjVlKpeScTtDiCTR4q3yjV9G9Kq3ZvKkVxFfKQRU9hNu1sV3fBsDoKPTRE9jGVEb7xjcueragfAfaH6H9WrUOjod6iF5urp_ni3j5eHs3v1zGijHm46xOiiThWFSS4lRyQQTlYVLUUoBSRGBaKcUSmmGuSJnxgqcgiwLzSspEAjtEZ9u7G2vee3A-7xpXQtsqDaZ3ORU04yQRmAX0dED7ooMq39imU_Yj__k-ALMtEN52zkK9QwjOv_zmg9988BsS_FeibPy3m-Cwaf_JnW9zYZGvTW91cPQn_Qnjfo9v
CitedBy_id crossref_primary_10_3390_gels9030245
crossref_primary_10_1186_s13018_023_04120_w
crossref_primary_10_1016_j_mtbio_2025_101638
crossref_primary_10_1039_D3TB03070A
crossref_primary_10_3390_pharmaceutics16091175
crossref_primary_10_1002_adfm_202418407
crossref_primary_10_3389_fbioe_2024_1380528
crossref_primary_10_1002_advs_202302029
crossref_primary_10_34133_research_0478
crossref_primary_10_1186_s12951_024_02389_5
crossref_primary_10_1002_smll_202306191
crossref_primary_10_1021_acsnano_4c02316
crossref_primary_10_1016_j_xcrp_2024_102205
crossref_primary_10_1186_s11671_023_03946_x
crossref_primary_10_1016_j_cej_2024_158338
crossref_primary_10_1021_acsnano_3c00470
crossref_primary_10_1021_acsbiomaterials_3c00452
crossref_primary_10_1016_j_heliyon_2024_e32036
crossref_primary_10_1021_acsbiomaterials_3c00454
crossref_primary_10_1080_20002297_2024_2361403
crossref_primary_10_1186_s12951_023_01909_z
crossref_primary_10_1002_adma_202305633
crossref_primary_10_1080_17435889_2025_2469492
crossref_primary_10_1016_j_phrs_2023_107022
crossref_primary_10_1016_j_jconrel_2024_11_044
crossref_primary_10_1016_j_biopha_2025_117836
crossref_primary_10_1021_acsami_4c17436
crossref_primary_10_1021_acsabm_3c01213
crossref_primary_10_1021_acsnano_3c00578
crossref_primary_10_1016_j_actbio_2024_10_008
crossref_primary_10_1016_j_biopha_2023_114688
crossref_primary_10_1016_j_cej_2024_155694
crossref_primary_10_1186_s12951_023_02261_y
crossref_primary_10_2174_1389201024666230821090222
crossref_primary_10_1002_sstr_202300281
crossref_primary_10_2147_IJN_S497590
crossref_primary_10_1016_j_cej_2024_157433
crossref_primary_10_1039_D4NR02480J
crossref_primary_10_1186_s12951_024_02801_0
crossref_primary_10_1002_advs_202403786
crossref_primary_10_1021_acs_inorgchem_4c01189
crossref_primary_10_3390_ijms24043158
crossref_primary_10_3390_ijms26072894
crossref_primary_10_1002_smll_202400771
crossref_primary_10_1016_j_cej_2024_157660
crossref_primary_10_1088_1748_605X_ad4aaa
crossref_primary_10_1002_adfm_202301062
crossref_primary_10_1016_j_colsurfb_2025_114604
crossref_primary_10_1002_smtd_202301178
crossref_primary_10_1021_acsnano_3c06711
crossref_primary_10_1021_acsbiomaterials_4c00220
crossref_primary_10_2147_IJN_S465959
crossref_primary_10_1007_s10753_024_02168_2
crossref_primary_10_3389_fphar_2024_1533964
Cites_doi 10.1128/IAI.01069-16
10.1038/nrd3669
10.1002/adma.201804023
10.1016/j.matt.2021.08.015
10.1021/ja301167y
10.1016/j.matt.2021.11.017
10.1111/j.1600-051X.2010.01678.x
10.1016/j.biomaterials.2018.05.034
10.1038/s41551-017-0115-8
10.1038/s41577-020-00488-6
10.1002/btm2.10197
10.1902/jop.2013.130280
10.1146/annurev.immunol.23.021704.115816
10.1021/nn3008383
10.2147/IJN.S244849
10.1902/jop.2005.76.9.1601
10.1038/s41579-018-0089-x
10.1021/acsnano.9b03237
10.1021/acsnano.6b03148
10.1038/s41579-020-0420-1
10.1021/acsnano.6b04207
10.1021/acs.nanolett.8b01236
10.1038/nri1391
10.1002/adma.201905145
10.1007/s00253-010-2687-z
10.1038/nnano.2009.153
10.1038/s41565-021-00923-2
10.1034/j.1600-0757.2003.03105.x
10.1002/adma.202005423
10.1126/scitranslmed.aat0797
10.1038/s41565-018-0254-4
10.1021/acsami.0c17235
10.1111/jcpe.12732
10.1016/j.immuni.2011.05.006
10.1016/j.biomaterials.2020.120159
10.1016/j.ijantimicag.2009.12.011
10.1016/j.apmt.2019.100505
10.1002/adfm.201801355
10.1038/nmicrobiol.2016.162
10.1016/j.cell.2006.02.015
10.1021/jacs.5b11411
10.1002/smll.202006484
10.1088/1361-6528/aaa7c7
10.1016/j.chom.2014.05.012
10.1016/j.chom.2011.10.006
ContentType Journal Article
Copyright 2022 American Chemical Society
Copyright_xml – notice: 2022 American Chemical Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1021/acsnano.2c05923
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 1936-086X
EndPage 18265
ExternalDocumentID 36288552
10_1021_acsnano_2c05923
a172996577
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.K2
23M
4.4
55A
5GY
5VS
6J9
7~N
AABXI
ABFRP
ABMVS
ABQRX
ABUCX
ACGFO
ACGFS
ACS
ADHLV
AEESW
AENEX
AFEFF
AHGAQ
ALMA_UNASSIGNED_HOLDINGS
AQSVZ
CS3
EBS
ED~
F5P
GGK
GNL
IH9
IHE
JG~
P2P
RNS
ROL
UI2
VF5
VG9
W1F
XKZ
YZZ
AAHBH
AAYXX
ABBLG
ABJNI
ABLBI
ACBEA
ADHGD
BAANH
CITATION
CUPRZ
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-a333t-9f4b44507d82068571725b44bf87eaa1702daa342905a1c95b56e8bb05d8848e3
IEDL.DBID ACS
ISSN 1936-0851
1936-086X
IngestDate Fri Jul 11 13:32:47 EDT 2025
Mon Jul 21 06:04:15 EDT 2025
Thu Apr 24 22:59:39 EDT 2025
Tue Jul 01 03:37:32 EDT 2025
Thu Nov 24 04:02:03 EST 2022
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords Porphyromonas gingivalis
membrane cloaking nanoparticle
periodontitis treatment
responsive hydrogel
host immune dysfunction
Language English
License https://doi.org/10.15223/policy-029
https://doi.org/10.15223/policy-037
https://doi.org/10.15223/policy-045
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a333t-9f4b44507d82068571725b44bf87eaa1702daa342905a1c95b56e8bb05d8848e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-1900-6405
0000-0002-9586-9360
0000-0002-6027-0315
PMID 36288552
PQID 2729514703
PQPubID 23479
PageCount 13
ParticipantIDs proquest_miscellaneous_2729514703
pubmed_primary_36288552
crossref_primary_10_1021_acsnano_2c05923
crossref_citationtrail_10_1021_acsnano_2c05923
acs_journals_10_1021_acsnano_2c05923
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20221122
2022-11-22
PublicationDateYYYYMMDD 2022-11-22
PublicationDate_xml – month: 11
  year: 2022
  text: 20221122
  day: 22
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle ACS nano
PublicationTitleAlternate ACS Nano
PublicationYear 2022
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
References ref9/cit9
ref45/cit45
ref6/cit6
ref36/cit36
ref3/cit3
ref27/cit27
ref18/cit18
ref11/cit11
ref25/cit25
ref16/cit16
ref29/cit29
ref32/cit32
ref23/cit23
ref39/cit39
ref14/cit14
ref8/cit8
ref5/cit5
ref31/cit31
ref2/cit2
ref43/cit43
ref34/cit34
ref37/cit37
ref28/cit28
ref40/cit40
ref20/cit20
ref17/cit17
ref10/cit10
ref26/cit26
ref35/cit35
ref19/cit19
ref21/cit21
ref12/cit12
ref15/cit15
ref42/cit42
ref41/cit41
ref22/cit22
ref13/cit13
ref33/cit33
ref4/cit4
ref30/cit30
ref1/cit1
ref24/cit24
ref38/cit38
ref44/cit44
ref7/cit7
References_xml – ident: ref42/cit42
  doi: 10.1128/IAI.01069-16
– ident: ref8/cit8
  doi: 10.1038/nrd3669
– ident: ref11/cit11
  doi: 10.1002/adma.201804023
– ident: ref13/cit13
  doi: 10.1016/j.matt.2021.08.015
– ident: ref29/cit29
  doi: 10.1021/ja301167y
– ident: ref2/cit2
  doi: 10.1016/j.matt.2021.11.017
– ident: ref25/cit25
  doi: 10.1111/j.1600-051X.2010.01678.x
– ident: ref39/cit39
  doi: 10.1016/j.biomaterials.2018.05.034
– ident: ref40/cit40
  doi: 10.1038/s41551-017-0115-8
– ident: ref4/cit4
  doi: 10.1038/s41577-020-00488-6
– ident: ref23/cit23
  doi: 10.1002/btm2.10197
– ident: ref7/cit7
  doi: 10.1902/jop.2013.130280
– ident: ref12/cit12
  doi: 10.1146/annurev.immunol.23.021704.115816
– ident: ref34/cit34
  doi: 10.1021/nn3008383
– ident: ref18/cit18
  doi: 10.2147/IJN.S244849
– ident: ref1/cit1
  doi: 10.1902/jop.2005.76.9.1601
– ident: ref5/cit5
  doi: 10.1038/s41579-018-0089-x
– ident: ref44/cit44
  doi: 10.1021/acsnano.9b03237
– ident: ref10/cit10
  doi: 10.1021/acsnano.6b03148
– ident: ref28/cit28
  doi: 10.1038/s41579-020-0420-1
– ident: ref36/cit36
  doi: 10.1021/acsnano.6b04207
– ident: ref19/cit19
  doi: 10.1021/acs.nanolett.8b01236
– ident: ref27/cit27
  doi: 10.1038/nri1391
– ident: ref41/cit41
  doi: 10.1002/adma.201905145
– ident: ref31/cit31
  doi: 10.1007/s00253-010-2687-z
– ident: ref30/cit30
  doi: 10.1038/nnano.2009.153
– ident: ref43/cit43
  doi: 10.1038/s41565-021-00923-2
– ident: ref24/cit24
  doi: 10.1034/j.1600-0757.2003.03105.x
– ident: ref32/cit32
  doi: 10.1002/adma.202005423
– ident: ref6/cit6
  doi: 10.1126/scitranslmed.aat0797
– ident: ref14/cit14
  doi: 10.1038/s41565-018-0254-4
– ident: ref21/cit21
  doi: 10.1021/acsami.0c17235
– ident: ref3/cit3
  doi: 10.1111/jcpe.12732
– ident: ref9/cit9
  doi: 10.1016/j.immuni.2011.05.006
– ident: ref16/cit16
  doi: 10.1016/j.biomaterials.2020.120159
– ident: ref37/cit37
  doi: 10.1016/j.ijantimicag.2009.12.011
– ident: ref22/cit22
  doi: 10.1016/j.apmt.2019.100505
– ident: ref15/cit15
  doi: 10.1002/adfm.201801355
– ident: ref35/cit35
  doi: 10.1038/nmicrobiol.2016.162
– ident: ref26/cit26
  doi: 10.1016/j.cell.2006.02.015
– ident: ref33/cit33
  doi: 10.1021/jacs.5b11411
– ident: ref20/cit20
  doi: 10.1002/smll.202006484
– ident: ref17/cit17
  doi: 10.1088/1361-6528/aaa7c7
– ident: ref38/cit38
  doi: 10.1016/j.chom.2014.05.012
– ident: ref45/cit45
  doi: 10.1016/j.chom.2011.10.006
SSID ssj0057876
Score 2.61595
Snippet Periodontitis is a chronic inflammatory disease caused by the interaction of oral microorganisms with the host immune response. Porphyromonas gingivalis (P.g.)...
Periodontitis is a chronic inflammatory disease caused by the interaction of oral microorganisms with the host immune response. (P.g.) acts as a key mediator...
SourceID proquest
pubmed
crossref
acs
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 18253
SubjectTerms Cytokines
Humans
Macrophages - metabolism
Periodontitis - drug therapy
Periodontitis - metabolism
Porphyromonas gingivalis - physiology
Title Penetrating Macrophage-Based Nanoformulation for Periodontitis Treatment
URI http://dx.doi.org/10.1021/acsnano.2c05923
https://www.ncbi.nlm.nih.gov/pubmed/36288552
https://www.proquest.com/docview/2729514703
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ZS8NAEF60vuiD91EvIvTBl43JHjketViKUCnYQt_CHlkFJRGTvvjrnc1RL4q-JSG7JDOzM98wu98g1AuM5CQKIC1R0mDGaYjjkCgcGqMEI0J4nj07PLoPhlN2N-OzT7LonxV84l8JVWQiy12iAAkQuorWSABGZlFQ_6F1utbugrqADAkyoIgFi8-vCWwYUsX3MLQEW1YxZrBV784qKmpCu7Xk2Z2X0lXvv4kb__78bbTZIE3nujaNHbSSZrto4wv_4B4ajsHTVby52aMzErab1xP4F3wDoU074HhzC2mbBl8OXDtjGAmJbEXEWjiTdpf6PpoObif9IW5aK2BBKS1xbJhkDLCgtvztEYekjnB4Ik0UpkL4oUe0EBSClceFr2IueZBGUnpcRxGLUnqAOlmepUfICXUAc1CpY-MxA06L6hhuYqEZKIPKLuqBDJJmaRRJVfUmftIIJmkE00Vuq5BENfTktkvGy_IBl4sBrzUzx_JXL1oNJ7B6bElEZGk-LxICuQVARnB7XXRYq34xGbWdmDknx__7gRO0TuzRCN_HhJyiTvk2T88AsJTyvDLVDz2d5ZU
linkProvider American Chemical Society
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3JTsMwEB2VcgAO7EtZg9QDl5TES5ZjqagCtFURrdRbZGcBCZQg0l74esZpEjZVglsSxSMv45k3GvsNQNOKJSeOhWFJIGOdcWrrrk0C3Y7jQDAihGGou8P9geWN2e2ET2pglHdhsBMZSsryJP4nu4B5id8SkaQtEiAgIHQJlhGKEFWsod15KG2vUj9rnkfGOBnBREXm80uA8kZB9t0bLYCYuavpbsB91cn8hMlzazaVreD9B3_jf0axCesF7tTac0XZglqUbMPaFzbCHfCGaPdyFt3kUesLVdvrCa2NfoWOLtTQDKcK4BblvjR81obYEsPanJY100blmfVdGHevRx1PLwot6IJSOtXdmEnGEBmGis3d4RjiEY5fZOzYkRCmbZBQCIquy-DCDFwuuRU5Uho8dBzmRHQP6kmaRAeg2aGFMqgM3dhgMZowGrr44oqQ4ZpQ2YAmzoFfbJTMz3PgxPSLifGLiWlAq1wXPyjIylXNjJfFDS6qBq9zno7Fv56XC-3jXlIJEpFE6SzzCUYaCCDRCDZgf64BlTCq6jJzTg7_NoAzWPFG_Z7fuxncHcEqUZcmTFMn5Bjq07dZdIJQZipPc-39AFJG7fY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZS8NAEB60guiD91HPCH3wJTXZI8djrZZ6tBS04FvYzWYVlLSY9sVf72y6LR4U9C0J2WWP2ZlvmJ1vAGqBlpxEAbolqdQu4zR045Ckbqh1KhgRwvNM7nCnG7T77PaJP9mkMJMLg4MosKeiDOKbUz1U2jIM-Bf4PRf5oE5SBAWELsKSCdqZgg2N5sNU_xoRDCaxZPSVEVDMCH1-dWAsUlp8t0hzYGZpblrr0J8NtLxl8lofj2Q9_fjB4fjfmWzAmsWfTmMiMJuwkOVbsPqFlXAb2j3UfyWbbv7sdISp8fWCWse9RIOnHFTHAwN0bdkvB5-dHrZE97akZy2cx-nd9R3ot64fm23XFlxwBaV05MaaScYQISrD6h5xdPUIxy9SR2EmhB96RAlB0YR5XPhpzCUPskhKj6soYlFGd6GSD_JsH5xQBdgHlSrWHtOoyqiK8SUWiuG-UFmFGq5BYg9MkZSxcOIndmESuzBVqE_3JkktabmpnfE2v8H5rMFwwtcx_9ez6WYneKZMoETk2WBcJAQ9DgSSqAyrsDeRglln1NRn5pwc_G0Cp7Dcu2ol9zfdu0NYISZ3wvddQo6gMnofZ8eIaEbypBTgTxol8Hk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Penetrating+Macrophage-Based+Nanoformulation+for+Periodontitis+Treatment&rft.jtitle=ACS+nano&rft.au=Yan%2C+Na&rft.au=Xu%2C+Junchao&rft.au=Liu%2C+Guolin&rft.au=Ma%2C+Chao&rft.date=2022-11-22&rft.pub=American+Chemical+Society&rft.issn=1936-0851&rft.eissn=1936-086X&rft.volume=16&rft.issue=11&rft.spage=18253&rft.epage=18265&rft_id=info:doi/10.1021%2Facsnano.2c05923&rft.externalDocID=a172996577
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1936-0851&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1936-0851&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1936-0851&client=summon